The calpain inhibitor A-705253 attenuates alcohol-seeking and relapse with low side-effect profile
Preclinical studies revealed contribution of N-methyl-D-aspartate receptors (NMDARs) to a variety of neuropsychiatric diseases including alcoholism, but development of NMDAR antagonists for therapeutic use has been a challenge, in part due to severe side effects. One of the key intracellular events...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
Neuropsychopharmacology
Year: 2015, Jahrgang: 41, Heft: 4, Pages: 979-988 |
| ISSN: | 1740-634X |
| DOI: | 10.1038/npp.2015.225 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/npp.2015.225 Verlag, Volltext: https://www-nature-com.ezproxy.medma.uni-heidelberg.de/articles/npp2015225 
|
| Verfasserangaben: | Valentina Vengeliene, Achim Moeller, Marcus W. Meinhardt, Patrick M. Beardsley, Wolfgang H. Sommer, Rainer Spanagel and Anton Bespalov |
| Zusammenfassung: | Preclinical studies revealed contribution of N-methyl-D-aspartate receptors (NMDARs) to a variety of neuropsychiatric diseases including alcoholism, but development of NMDAR antagonists for therapeutic use has been a challenge, in part due to severe side effects. One of the key intracellular events resulting from stimulation of NMDAR is activation of calpains-calcium-dependent cysteine proteases. Here we studied whether inhibition of calpains would produce therapeutic-like effects of NMDAR antagonists but without their NMDAR-mediated side-effect profile. The calpain inhibitor A-705253 (3-10 mg/kg) was tested in a model of cue-induced reinstatement of alcohol-seeking behavior in post-dependent Wistar rats and in an alcohol deprivation effect (ADE) model in long-term alcohol drinking Wistar rats, two behavioral models for alcohol-seeking and relapse, respectively. We also tested the effect of A-705253 on the saccharine deprivation effect (SDE) as a selectivity measure. Acute treatment with A-705253 dose-dependently reduced cue-induced reinstatement of alcohol-seeking behavior. Repeated administration of A-705253 caused significant reductions of relapse-like excessive alcohol intake during the post-abstinence drinking days, an effect that persisted during two more successive drug-free drinking weeks, which was selective for the ADE as the SDE was unaffected. However, A-705253 did not produce psychostimulant, cognition impairing (delayed-matching-to-position), or psychotomimetic effects (specifically, phencyclidine discriminative stimulus effects). Taken together, these results demonstrate the involvement of calpains in alcohol-seeking and relapse and present a rationale for a novel pharmacological intervention that may reduce craving and relapse with minimal side effects in alcohol-dependent patients. |
|---|---|
| Beschreibung: | Gesehen am 27.03.2019 Published online 16 September 2015 |
| Beschreibung: | Online Resource |
| ISSN: | 1740-634X |
| DOI: | 10.1038/npp.2015.225 |